Literature DB >> 1178201

Adjunctive measures in rhinoplasty.

R L Simons.   

Abstract

Modern day rhinoplasty demands more than a plan for a new nose. It requires consideration of the individual in terms of a new facial image. Adjacent skeletal and soft tissue weaknesses must be evaluated along with the primary nasal deformity. Frequently facial disharmonies may be corrected with relatively simple operative procedures or with cosmetics. When the procedure does not measurably increase the operative time, postoperative morbidity, or financial cose of the rhinoplasty, it will be more readily accepted by the patient. These criteria are considered in the suggested methods of chin augmentation with alloplastic implants and reduction mentoplasty, utilizing the intraoral subapical horizontal osteotomy of the mandible. At times, simple methods of camouflage will be inadequate. Significant jaw disharmony with unacceptable occlusion requires the interdisciplinary teamwork of the orthodontist, the surgeon, and possibly the prosthodontist. In these cases rhinoplasty waits upon skeletal and dental realignment. Almost without exception, the rhinoplasty patient appreciates and profits from the surgeon's concern over her general appearance. Advice regarding skin care, makeup, hair styling, and facial rejuvenation frequently aids that person in attaining a happy and satisfying rhinoplastic experience.

Entities:  

Mesh:

Year:  1975        PMID: 1178201

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  2 in total

1.  Estimating implant size in chin augmentation: A simplified approach.

Authors:  Nabil Fanous; Adi Yoskovitch
Journal:  Can J Plast Surg       Date:  2003

2.  Anthropometric study of the caucasian nose in the city of Curitiba: relevance of population evaluation.

Authors:  Annelyse Cristine Ballin; Bettina Carvalho; José Eduardo Lutaif Dolci; Renata Becker; Cezar Berger; Marcos Mocellin
Journal:  Braz J Otorhinolaryngol       Date:  2017-07-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.